Angelica keiskei ameliorates scopolamine-induced memory impairments in mice

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 1, 2013, Pages 82-88

  Oh, Sa Rang ^a   Kim, Su Jin ^b   Kim, Dong Hyun ^c   Ryu, Jong Hoon ^c   Ahn, Eun Mi ^b   Jung, Ji Wook ^b  

^a Keimyung University   (South Korea)

^b Daegu Haany University   (South Korea)

^c Kyung Hee University   (South Korea)

Author keywords

Acetylcholinesterase; Angelica keiskei; Brain derived neurotrophic factor; cAMP response element binding protein; Memory impairment; Scopolamine

Indexed keywords

ACETYLCHOLINESTERASE; ANGELICA KEISKEI EXTRACT; BRAIN DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PLANT EXTRACT; SCOPOLAMINE; TACRINE; UNCLASSIFIED DRUG;

ANGELICA; ANGELICA KEISKEI; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICHOLINERGIC EFFECT; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME ASSAY; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; MALE; MAZE TEST; MEMORY DISORDER; MENTAL TASK; MOUSE; NONHUMAN; PASSIVE AVOIDANCE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; WESTERN BLOTTING;

ACETYLCHOLINESTERASE; ANGELICA; ANIMALS; AVOIDANCE LEARNING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; MALE; MEMORY DISORDERS; MICE; MICE, INBRED ICR; PHYTOTHERAPY; PLANT EXTRACTS; PLANT LEAVES; SCOPOLAMINE HYDROBROMIDE;

EID: 84872724945     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b12-00681     Document Type: Article

References (31)

1. Terry AV Jr, Buccafusco JJ. The cholinergic hypothesis of age and Alzheimer's disease-related cognitive deficits: recent challenges and their implications for novel drug development. J. Pharmacol. Exp. Ther., 306, 821-827 (2003).
2. Power AE, Vazdarjanova A, McGaugh JL. Muscarinic cholinergic influences in memory consolidation. Neurobiol. Learn. Mem., 80, 178-193 (2003).
3. Hasselmo ME. The role of acetylcholine in learning and memory. Curr. Opin. Neurobiol., 16, 710-715 (2006).
4. Chang Q, Gold PE. Switching memory systems during learning: changes in patterns of brain acetylcholine release in the hippocampus and striatum in rats. J. Neurosci., 23, 3001-3005 (2003).
5. Fadda F, Cocco S, Stancampiano R. Hippocampal acetylcholine release correlates with spatial learning performance in freely moving rats. Neuroreport, 11, 2265-2269 (2000).
6. Ballard CG, Greig NH, Guillozet-Bongaarts AL, Enz A, Darvesh S. Cholinesterases: roles in the brain during health and disease. Curr. Alzheimer Res., 2, 307-318 (2005).
7. Ahmed T, Gilani AH. Inhibitory effect of curcuminoids on acetylcholinesterase activity and attenuation of scopolamine-induced amnesia may explain medicinal use of turmeric in Alzheimer's disease. Pharmacol. Biochem. Behav., 91, 554-559 (2009).
8. Lahiri DK, Farlow MR, Sambamurti K, Greig NH, Giacobini E, Schneider LS. A critical analysis of new molecular targets and strategies for drug developments in Alzheimer's disease. Curr. Drug Targets, 4, 97-112 (2003).
9. Heinrich M, Lee Teoh H. Galanthamine from snowdrop - the development of a modern drug against Alzheimer's disease from local Caucasian knowledge. J. Ethnopharmacol., 92, 147-162 (2004).
10. Yang JH, Han SJ, Ryu JH, Jang IS, Kim DH. Ginsenoside Rh2 ameliorates scopolamine-induced learning deficit in mice. Biol. Pharm. Bull., 32, 1710-1715 (2009).
11. Kida S, Josselyn SA, Peña de Ortiz S, Kogan JH, Chevere I, Masushige S, Silva AJ. CREB required for the stability of new and reactivated fear memories. Nat. Neurosci., 5, 348-355 (2002).
12. Pittenger C, Huang YY, Paletzki RF, Bourtchouladze R, Scanlin H, Vronskaya S, Kandel ER. Reversible inhibition of CREB/ATF transcription factors in region CA1 of the dorsal hippocampus disrupts hippocampus-dependent spatial memory. Neuron, 34, 447-462 (2002).
13. Korzus E, Rosenfeld MG, Mayford M. CBP histone acetyltransferase activity is a critical component of memory consolidation. Neuron, 42, 961-972 (2004).
14. Saura CA, Valero J. The role of CREB signaling in Alzheimer's disease and other cognitive disorders. Rev. Neurosci., 22, 153-169 (2011).
15. Kozisek ME, Middlemas D, Bylund DB. Brain-derived neurotrophic factor and its receptor tropomyosin-related kinase B in the mechanism of action of antidepressant therapies. Pharmacol. Ther., 117, 30-51 (2008).
16. Pezet S, Malcangio M, McMahon SB. BDNF: a neuromodulator in nociceptive pathways? Brain Res. Brain Res. Rev., 40, 240-249 (2002).
17. Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, Izquierdo I, Medina JH. BDNF is essential to promote persistence of long-term memory storage. Proc. Natl. Acad. Sci. U.S.A., 105, 2711-2716 (2008).
18. Inamori Y, Baba K, Tsujibo H, Taniguchi M, Nakata K, Kozawa M. Antibacterial activity of two chalcones, xanthoangelol and 4-hydroxyderricin, isolated from the root of Angelica keiskei Koidzumi. Chem. Pharm. Bull., 39, 1604-1605 (1991).
19. Okuyama T, Takata M, Takayasu J, Hasegawa T, Tokuda H, Nishino A, Nishino H, Iwashima A. Anti-tumor-promotion by principles obtained from Angelica keiskei. Planta Med., 57, 242-246 (1991).
20. Ogawa H, Nakashima S, Baba K. Effects of dietary Angelica keiskei on lipid metabolism in stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol., 30, 284-288 (2003).
21. Sun XL, Ito H, Masuoka T, Kamei C, Hatano T. Effect of Polygala tenuifolia root extract on scopolamine-induced impairment of rat spatial cognition in an eight-arm radial maze task. Biol. Pharm. Bull., 30, 1727-1731 (2007).
22. Wang Q, Sun LH, Jia W, Liu XM, Dang HX, Mai WL, Wang N, Steinmetz A, Wang YQ, Xu CJ. Comparison of ginsenosides Rg1 and Rb1 for their effects on improving scopolamine-induced learning and memory impairment in mice. Phytother. Res., 24, 1748-1754 (2010).
23. Rao P, Suzuki R, Mizobuchi S, Yamaguchi T, Sasaguri S. Bilirubin exhibits a novel anti-cancer effect on human adenocarcinoma. Biochem. Biophys. Res. Commun., 342, 1279-1283 (2006).
24. Kim DH, Hung TM, Bae KH, Jung JW, Lee S, Yoon BH, Cheong JH, Ko KH, Ryu JH. Gomisin A improves scopolamine-induced memory impairment in mice. Eur. J. Pharmacol., 542, 129-135 (2006).
25. Bullock R. New drugs for Alzheimer's disease and other dementias. Br. J. Psychiatry, 180, 135-139 (2002).
26. Cummings JL. Alzheimer's disease. N. Engl. J. Med., 351, 56-67 (2004).
27. Kang SY, Lee KY, Park MJ, Kim YC, Markelonis GJ, Oh TH, Kim YC. Decursin from Angelica gigas mitigates amnesia induced by scopolamine in mice. Neurobiol. Learn. Mem., 79, 11-18 (2003).
28. Nielsen JA, Mena EE, Williams IH, Nocerini MR, Liston D. Correlation of brain levels of 9-amino-1,2,3,4-tetrahydroacridine (THA) with neurochemical and behavioral changes. Eur. J. Pharmacol., 173, 53-64 (1989).
29. Jung WY, Park SJ, Park DH, Kim JM, Kim DH, Ryu JH. Quercetin impairs learning and memory in normal mice via suppression of hippocampal phosphorylated cyclic AMP response element-binding protein expression. Toxicol. Lett., 197, 97-105 (2010).
30. Kim JM, Kim DH, Park SJ, Park DH, Jung SY, Kim HJ, Lee YS, Jin C, Ryu JH. The n-butanolic extract of Opuntia ficus-indica var. saboten enhances long-term memory in the passive avoidance task in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 34, 1011-1017 (2010).
31. Williams CM, El Mohsen MA, Vauzour D, Rendeiro C, Butler LT, Ellis JA, Whiteman M, Spencer JP. Blueberry-induced changes in spatial working memory correlate with changes in hippocampal CREB phosphorylation and brain-derived neurotrophic factor (BDNF) levels. Free Radic. Biol. Med., 45, 295-305 (2008).